Who
Alexandria Forbes
President & CEO
Company insider
Files Form 4 as: President & CEO, MeiraGTx Holdings; Director, Kadmon Holdings.
In numbers
- Trades disclosed
- 104
- Buys
- 0
- Sells
- 31
- Bought
- $0
- Sold
- $9.4M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 15 Dec 2016
- Last trade
- 18 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Aug 2026filed 18 Aug 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $859K62,000 at $13.86 | filing |
| 18 Aug 2026filed 18 Aug 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $859K62,000 at $13.86 | filing |
| 25 Jun 2026filed 29 Jun 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —980,000 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —980,000 at $0.00 | filing |
| 19 May 2026filed 19 May 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $569K62,000 at $9.17 | filing |
| 19 May 2026filed 19 May 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $569K62,000 at $9.17 | filing |
| 24 Mar 2026filed 24 Mar 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $459K62,000 at $7.41 | filing |
| 24 Mar 2026filed 24 Mar 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Sold | $459K62,000 at $7.41 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —62,500 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $246K33,048 at $7.45 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —62,500 at $0.00 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —62,500 at $0.00 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —62,500 | filing |
| 21 Feb 2026filed 23 Feb 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $246K33,048 at $7.45 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —310,000 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $1.2M163,916 at $7.42 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —310,000 at $0.00 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —310,000 at $0.00 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code M | —310,000 | filing |
| 17 Jan 2026filed 21 Jan 2026 | MGTX MeiraGTx HoldingsBiotechnology | SEC FORM 4 Code F | $1.2M163,916 at $7.42 | filing |
News
Critical Contrast: Stoke Therapeutics (NASDAQ:STOK) vs. MeiraGTx (NASDAQ:MGTX)MGTX · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Alexandria Forbes; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.